SCANO, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 445
EU - Europa 270
AS - Asia 186
AF - Africa 23
SA - Sud America 9
Totale 933
Nazione #
US - Stati Uniti d'America 439
IT - Italia 169
SG - Singapore 99
CN - Cina 46
HK - Hong Kong 29
DE - Germania 26
CI - Costa d'Avorio 19
FI - Finlandia 16
NL - Olanda 16
FR - Francia 11
SE - Svezia 10
RU - Federazione Russa 8
BR - Brasile 7
EG - Egitto 4
GB - Regno Unito 4
JP - Giappone 4
MX - Messico 4
AT - Austria 2
CA - Canada 2
CO - Colombia 2
ID - Indonesia 2
IE - Irlanda 2
PK - Pakistan 2
TR - Turchia 2
UA - Ucraina 2
BE - Belgio 1
BY - Bielorussia 1
IN - India 1
MY - Malesia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 933
Città #
Chandler 60
Padova 55
Singapore 46
Charlottesville 37
Santa Clara 36
Fairfield 30
Hong Kong 28
Cambridge 23
Milan 21
Abidjan 19
Ashburn 19
Boardman 16
Beijing 14
Helsinki 14
Wilmington 14
Seattle 13
Medford 10
Princeton 10
San Diego 9
Houston 8
Woodbridge 8
Des Moines 7
Amsterdam 5
Falkenstein 5
Rubano 5
Trento 5
Cagliari 4
Cairo 4
Genoa 4
New York 4
Tlalpan 4
Nuremberg 3
Paese 3
Rome 3
Usuki 3
Ann Arbor 2
Bogotá 2
Brendola 2
Campo San Martino 2
Catania 2
Dublin 2
Due Carrare 2
Fossò 2
Frattamaggiore 2
Giugliano in Campania 2
Izmir 2
Kharkiv 2
Lappeenranta 2
London 2
Munich 2
Pontedera 2
Roxbury 2
Sanluri 2
Sant'Anastasia 2
St Louis 2
Toronto 2
Treviso 2
Venice 2
Apucarana 1
Arzignano 1
Atlanta 1
Baltimore 1
Bari 1
Belluno 1
Blacksburg 1
Bratislava 1
Brussels 1
Busto Arsizio 1
Carol Stream 1
Cassino 1
Charlotte 1
Fernandópolis 1
Fontanelle 1
Forest Park 1
Frankfurt am Main 1
Goiana 1
Greenville 1
Henrico 1
Jesolo 1
Los Angeles 1
Maserà di Padova 1
Mato Rico 1
Minsk 1
Montecchio Maggiore 1
New Bedfont 1
Ogden 1
Ponzano Veneto 1
Pune 1
Reggio Calabria 1
Rimini 1
Rio de Janeiro 1
San Giovanni Lupatoto 1
San Jose 1
Santarém 1
Sunderland 1
São Paulo 1
Talence 1
Tokyo 1
Verona 1
Vienna 1
Totale 637
Nome #
I correttori del CFTR come nuovo approccio farmacologico per le sarcoglicanopatie 144
CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3 103
Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery 98
In vivo recovery of α-sarcoglycan mutants by protein folding correctors 58
Zebrafish as a model for sarcoglycanopathies: in-depth analysis of the disease phenotype 57
Reciprocal homer1a and homer2 isoform expression is a key mechanism for muscle soleus atrophy in spaceflown mice 57
In vivo recovery of α-sarcoglycan mutants by protein folding correctors 53
Novel animal models for sarcoglycanopathy 53
Novel zebrafish models for sarcoglycanopathy 50
C17 corrector for the treatment of sarcoglycanopathy: preliminary ADME studies 48
In vivo rescue of α-sarcoglycan mutants by CFTR correctors 48
Synthesis and Evaluation of Bithiazole Derivatives As Potential α-Sarcoglycan Correctors 41
Modeling Sarcoglycanopathy in Danio rerio 32
Small molecules to rescue folding-defective sarcoglycans: in vivo assessment of novel therapeutic strategies 32
Advanced therapeutic approaches in sarcoglycanopathies 31
In vivo proof of concept of the efficacy of the CFTR corrector C17 in a sarcoglycanopathy mouse model 25
null 17
The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy 13
Efficacy of Cystic Fibrosis Transmembrane Regulator Corrector C17 in Beta-Sarcoglycanopathy—Assessment of Patient’s Primary Myotubes 11
Totale 971
Categoria #
all - tutte 4.831
article - articoli 2.978
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.809


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 5 4 0
2020/202120 4 0 7 0 0 0 0 2 3 2 0 2
2021/2022141 2 6 15 21 4 7 15 13 22 6 4 26
2022/2023125 17 7 5 6 26 17 2 8 18 2 12 5
2023/2024240 15 30 19 16 24 16 23 41 6 13 19 18
2024/2025428 5 60 24 25 62 16 41 117 61 17 0 0
Totale 971